Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.23.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Class A Common Stock
Common Stock
Class A Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Retained Earnings
Beginning balance (in shares) at Dec. 30, 2021     105,761,000      
Beginning balance at Dec. 30, 2021 $ 1,323,199   $ 106 $ 450,332 $ 535 $ 872,226
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 5,980     5,980    
Exercise of stock options (in shares)     32,000      
Exercise of stock options 577     577    
Issuance of common stock upon vesting of restricted stock units (in shares)     47,000      
Shares issued under employee stock purchase plan (in shares)     21,000      
Shares issued under employee stock purchase plan 1,963     1,963    
Common stock redeemed for tax liability (in shares)     (19,000)      
Common stock redeemed for tax liability (1,807)     (1,807)    
Other comprehensive (loss) gain, net of tax 1,554       1,554  
Net income 70,951         70,951
Ending balance (in shares) at Mar. 31, 2022     105,842,000      
Ending balance at Mar. 31, 2022 1,402,417   $ 106 457,045 2,089 943,177
Beginning balance (in shares) at Dec. 30, 2021     105,761,000      
Beginning balance at Dec. 30, 2021 1,323,199   $ 106 450,332 535 872,226
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive (loss) gain, net of tax 2,376          
Net income 152,783          
Ending balance (in shares) at Jun. 30, 2022     105,993,000      
Ending balance at Jun. 30, 2022 1,494,286   $ 106 466,260 2,911 1,025,009
Beginning balance (in shares) at Mar. 31, 2022     105,842,000      
Beginning balance at Mar. 31, 2022 1,402,417   $ 106 457,045 2,089 943,177
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 4,889     4,889    
Exercise of stock options (in shares)     209,000      
Exercise of stock options 4,599     4,599    
Forfeiture of restricted stock awards (in shares)     (59,000)      
Issuance of common stock upon vesting of restricted stock units (in shares)     5,000      
Common stock redeemed for tax liability (in shares)     (4,000)      
Common stock redeemed for tax liability (273)     (273)    
Other comprehensive (loss) gain, net of tax 822       822  
Net income 81,832         81,832
Ending balance (in shares) at Jun. 30, 2022     105,993,000      
Ending balance at Jun. 30, 2022 1,494,286   $ 106 466,260 2,911 1,025,009
Beginning balance (in shares) at Dec. 29, 2022   106,150,661 106,151,000      
Beginning balance at Dec. 29, 2022 1,657,176   $ 106 482,312 4,337 1,170,421
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 6,741     6,741    
Exercise of stock options (in shares)     79,000      
Exercise of stock options 2,130     2,130    
Issuance of common stock upon vesting of restricted stock units (in shares)     117,000      
Shares issued under employee stock purchase plan (in shares)     43,000      
Shares issued under employee stock purchase plan 2,558     2,558    
Common stock redeemed for tax liability (in shares)     (119,000)      
Common stock redeemed for tax liability (10,863)     (10,863)    
Other comprehensive (loss) gain, net of tax (849)       (849)  
Net income 71,524         71,524
Ending balance (in shares) at Mar. 30, 2023     106,271,000      
Ending balance at Mar. 30, 2023 1,728,417   $ 106 482,878 3,488 1,241,945
Beginning balance (in shares) at Dec. 29, 2022   106,150,661 106,151,000      
Beginning balance at Dec. 29, 2022 $ 1,657,176   $ 106 482,312 4,337 1,170,421
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares) 201,891          
Other comprehensive (loss) gain, net of tax $ (975)          
Net income 142,976          
Ending balance (in shares) at Jun. 29, 2023   106,390,951 106,391,000      
Ending balance at Jun. 29, 2023 1,809,779   $ 106 492,914 3,362 1,313,397
Beginning balance (in shares) at Mar. 30, 2023     106,271,000      
Beginning balance at Mar. 30, 2023 1,728,417   $ 106 482,878 3,488 1,241,945
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 8,306     8,306    
Exercise of stock options (in shares)     123,000      
Exercise of stock options 2,728     2,728    
Issuance of common stock upon vesting of restricted stock units (in shares)     8,000      
Common stock redeemed for tax liability (in shares)     (11,000)      
Common stock redeemed for tax liability (998)     (998)    
Other comprehensive (loss) gain, net of tax (126)       (126)  
Net income 71,452         71,452
Ending balance (in shares) at Jun. 29, 2023   106,390,951 106,391,000      
Ending balance at Jun. 29, 2023 $ 1,809,779   $ 106 $ 492,914 $ 3,362 $ 1,313,397